Key result
Dietary intervention prevents age-related triglyceride rises in patients with the APOA5 TT genotype.
Why the study?
The effects of a 3-year dietary intervention on age-related changes in triglyceride and apo A-V levels in patients with IFG or new-onset type 2 diabetes according to the APOA5 -1131 T > C polymorphism were not well characterized.
Does a 3-year dietary intervention improve triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism?
Cohort (n=203)
No
Does a 3-year dietary intervention improve triglyceride and apolipoprotein A-V levels in patients with impaired fasting glucose or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism?
Absolute Event Rate: -7.88% vs 15%
p-value: p=0.001
A 3-year dietary intervention prevents age-related increases in triglycerides specifically in patients with IFG or new-onset T2DM who carry the APOA5 -1131 TT genotype.
Dietary effects on triglycerides may vary by APOA5 genotype in IFG or new-onset T2DM; hypothesis-generating and requires RCT confirmation before practice change.
BACKGROUND: The purpose of this study was to estimate the effects of a 3-year dietary intervention on age-related changes in triglyceride and apolipoprotein (apo A-V) levels in patients with impaired fasting glucose (IFG) or new-onset type 2 diabetes as a function of the APOA5 -1131 T > C polymorphism. METHODS: We genotyped the APOA5 -1131 T > C polymorphism in 203 Korean individuals with IFG or new-onset type 2 diabetes for the TT (n = 91), TC (n = 98), and CC (n = 14) alleles. Plasma apo A-V and triglyceride levels were evaluated at baseline and after a 3-year dietary intervention. RESULTS: Our results showed that HDL, glucose, insulin, HOMA-IR index, free fatty acids, and apo A-V decreased and brachial-ankle pulse wave velocity (ba-PWV) and malondialdehyde (MDA) increased at the 3-year follow-up visit compared with baseline. Plasma apo A-V levels were reduced in subjects with the C allele (TC or CC) (P = 0.036) and triglyceride levels were reduced in subjects with the TT allele (P = 0.047). Subjects with the C allele showed lower post-treatment apo A-V and higher post-treatment fasting triglyceride levels than subjects with the TT allele. Changes in apo A-V and triglyceride levels were negatively correlated in subjects with the TT allele and positively correlated in subjects with the C allele. CONCLUSIONS: This study showed that the dietary intervention prevented an age-related increase in triglyceride levels in individuals with IFG or new-onset type 2 diabetes who possess the TT allele, but not the CT or CC allele, of the APOA5 -1131 T > C polymorphism.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2014) conducted a cohort in Impaired fasting glucose or new-onset type 2 diabetes (n=203). APOA5 -1131 TT allele (during a 3-year dietary intervention) vs. APOA5 -1131 TC or CC allele was evaluated on Change in fasting triglyceride levels (mg/dL) (p=0.001). A 3-year dietary intervention prevented age-related increases in triglyceride levels in patients with impaired fasting glucose or new-onset type 2 diabetes who possessed the APOA5 -1131 TT allele, but not in those with the C allele.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: